Clinical trials tech startup expands its reach by acquiring key Flatiron Health assets and boosting innovation in digital research
Paradigm, a fast-growing clinical trials technology startup, has raised an impressive $78 million in new funding as it moves to reshape the future of digital research. In a major strategic step, the company has also acquired select assets from Roche’s Flatiron Health, strengthening its position in the rapidly evolving clinical tech market.
The latest funding highlights growing investor confidence in platforms that streamline research processes for pharmaceutical companies, healthcare providers, and patients. Paradigm aims to create a more efficient, patient-centered approach to clinical trials by reducing administrative friction and improving access to real-world data.
In announcing the funding round, Paradigm emphasized its mission to modernize research with tools that make trials more accessible, more transparent, and more connected. “Our goal is to accelerate medical innovation by building smarter, more integrated clinical trial systems,” a company representative explained.
By acquiring part of Flatiron Health, an industry leader known for oncology data and research technology, Paradigm gains valuable capabilities that will expand its reach across the clinical landscape. The integration is expected to enhance data quality, improve trial management, and support faster development of new therapies.
Experts say the growth of clinical trials technology reflects a wider shift toward decentralized, digitally supported research. With rising demand for faster drug development and more equitable patient participation, companies like Paradigm are setting the pace for the next era of medical discovery.
Conclusion:
Paradigm’s latest funding and strategic acquisition signal an important milestone in the evolution of clinical trials and digital research. As the startup continues to innovate, readers can stay informed by following, sharing, or commenting to join the conversation on the future of health tech.
